Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 2/20 | 0.44 |
| ▸ | HTR2A | P28223 | 2/20 | 0.44 |
| ▸ | DRD3 | P35462 | 2/20 | 0.44 |
| ▸ | BDKRB1 | P46663 | 2/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | CCR2 | P41597 | 9/20 | 0.43 |
| ▸ | GPR27 | Q9NS67 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3059294 | 1.00 | DRD2 (0.44) | DRD2HTR2ADRD3BDKRB1KCNH2 | |
| SCHEMBL3140960 | 0.93 | DRD2 (0.49) | DRD2HTR2ADRD3BDKRB1KCNH2 | |
| SCHEMBL3140964 | 0.93 | DRD2 (0.49) | DRD2HTR2ADRD3BDKRB1KCNH2 | |
| SCHEMBL15103718 | 0.89 | BDKRB1 (0.44) | BDKRB1KCNH2CCR2GPR27 | |
| SCHEMBL3049816 | 0.88 | BDKRB1 (0.56) | DRD2BDKRB1KCNH2CCR2 | |
| SCHEMBL3049821 | 0.88 | BDKRB1 (0.56) | DRD2BDKRB1KCNH2CCR2 | |
| Hydrochloric Acid SCHEMBL3059092 | 0.84 | GPR27 (0.44) | BDKRB1CCR2GPR27 | |
| SCHEMBL3274494 | 0.83 | CCR2 (0.46) | BDKRB1KCNH2CCR2GPR27 | |
| SCHEMBL3050733 | 0.82 | CCR2 (0.46) | HTR2ADRD3BDKRB1KCNH2CCR2 | |
| SCHEMBL3049324 | 0.82 | CCR2 (0.46) | HTR2ADRD3BDKRB1KCNH2CCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120295910-A1 | New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists | BEKE GYULA (HU) | 2012-11-22 | — | — | US | claimed |
| EP-2057116-B1 | NEW PHENYLSULFAMOYL BENZAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS | RICHTER GEDEON NYRT (HU) | 2013-02-13 | — | — | EP | disclosed |
| US-20130029991-A1 | New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists | BEKE GYULA (HU) | 2013-01-31 | — | — | US | disclosed |
| US-20120295910-A1 | New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists | BEKE GYULA (HU) | 2012-11-22 | — | — | US | disclosed |
| US-20100105686-A1 | PHENYLSULFAMOYL BENZAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS | RICHTER GEDEON NYRT. (HU) | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120295910-A1 | New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists | BDKRB1, BDKRB2, HRH4 | DRD2 462/4885HTR2A 771/4885DRD3 506/4885 |
| US-20130029991-A1 | New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists | BDKRB1, BDKRB2, HRH4 | DRD2 528/4885HTR2A 837/4885DRD3 582/4885 |
| US-20100105686-A1 | PHENYLSULFAMOYL BENZAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS | BDKRB1, BDKRB2, HRH1 | DRD2 485/4885HTR2A 781/4885DRD3 510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.